Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aspira Womans Health Inc | AWH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.39 | 04:09:32 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.39 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 2.3087 - 6.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 3.39 | USD |
Aspira Womans Health Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 41.35M | 10.34M | - | 9.15M | -16.69M | -1.61 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aspira Womans Health News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AWH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.50 | 3.57 | 3.2501 | 3.48 | 8,345 | -0.11 | -3.14% |
| 1 Month | 3.50 | 3.675 | 2.51 | 3.05 | 25,944 | -0.11 | -3.14% |
| 3 Months | 5.43 | 5.615 | 2.51 | 3.78 | 23,966 | -2.04 | -37.57% |
| 6 Months | 5.28 | 5.65 | 2.49 | 3.87 | 36,929 | -1.89 | -35.80% |
| 1 Year | 5.418 | 6.75 | 2.3087 | 4.15 | 67,011 | -2.03 | -37.43% |
| 3 Years | 90.75 | 95.85 | 2.3087 | 25.94 | 431,320 | -87.36 | -96.26% |
| 5 Years | 62.10 | 158.10 | 2.3087 | 44.00 | 506,571 | -58.71 | -94.54% |
Aspira Womans Health Description
| Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. Aspira GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment. |
